Can Singapore become a global hub for biotech?
Drug Discovery World
MARCH 13, 2024
Another successful NUS spin-out is RNA company Ephyra, now based in Cambridge, England, which is developing a new class of therapeutics known as designer sponge RNAs. Now we are still in collaboration to set up better infrastructure like a genome centre and translational laboratory in the health system.”
Let's personalize your content